ClinicalTrials.Veeva

Menu

Study to Evaluate Satisfaction After Treatment With Kysse

Galderma logo

Galderma

Status

Completed

Conditions

Lip Augmentation

Treatments

Device: Hyaluronic acid

Study type

Interventional

Funder types

Industry

Identifiers

NCT03967444
05DF1807

Details and patient eligibility

About

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.

Enrollment

59 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed and dated informed consent to participate in the study
  • Adult women and men who intend to undergo lip augmentation

Exclusion criteria

  • Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
  • Subjects with a previous implant other than HA in or near the intended treatment site
  • Participation in any other clinical study within three (3) months before treatment

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

59 participants in 2 patient groups

Restylane Kysse
Other group
Description:
Hyaluronic acid
Treatment:
Device: Hyaluronic acid
Device: Hyaluronic acid
Restylane Kysse with other HA
Other group
Description:
Hyaluronic acid
Treatment:
Device: Hyaluronic acid
Device: Hyaluronic acid

Trial documents
2

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems